Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-07-02 00:00:00 ET · period of report 2021-07-01 · accession 0001708138-21-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-07-02 | 2021-07-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $564.50 | -100 | 23.5K | -0.4% | -$56.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-01 | S | D | 13 | $568.43 | 23,491 | D | — | — | (F11) Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $568.10 to $568.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-07-01 | S | D | 13 | $567.56 | 23,504 | D | — | — | (F10) Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $567.15 to $567.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-07-01 | S | D | 6 | $564.71 | 23,542 | D | — | — | (F7) Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2021 at prices ranging from $564.26 to $564.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-07-01 | S | D | 13 | $565.44 | 23,529 | D | — | — | (F8) Represents volume-weighted average price of sales of 13 shares of Company stock on July 1, 2021 at prices ranging from $565.00 to $565.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-07-01 | S | D | 12 | $566.42 | 23,517 | D | — | — | (F9) Represents volume-weighted average price of sales of 12 shares of Company stock on July 1, 2021 at prices ranging from $566.09 to $566.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-07-01 | S | D | 2 | $555.47 | 23,589 | D | — | — | |
| 7 | Common | Common Stock | 2021-07-01 | S | D | 4 | $556.71 | 23,585 | D | — | — | (F2) Represents volume-weighted average price of sales of 4 shares of Company stock on July 1, 2021 at prices ranging from $556.60 to $556.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-07-01 | S | D | 1 | $557.75 | 23,584 | D | — | — | |
| 9 | Common | Common Stock | 2021-07-01 | S | D | 2 | $559.78 | 23,582 | D | — | — | |
| 10 | Common | Common Stock | 2021-07-01 | S | D | 2 | $560.62 | 23,580 | D | — | — | (F3) Represents volume-weighted average price of sales of 2 shares of Company stock on July 1, 2021 at prices ranging from $560.43 to $560.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-07-01 | S | D | 6 | $561.80 | 23,574 | D | — | — | (F4) Represents volume-weighted average price of sales of 6 shares of Company stock on July 1, 2021 at prices ranging from $561.57 to $561.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-07-01 | S | D | 10 | $562.48 | 23,564 | D | — | — | (F5) Represents volume-weighted average price of sales of 10 shares of Company stock on July 1, 2021 at prices ranging from $562.00 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |
| 13 | Common | Common Stock | 2021-07-01 | S | D | 16 | $563.40 | 23,548 | D | — | — | (F6) Represents volume-weighted average price of sales of 16 shares of Company stock on July 1, 2021 at prices ranging from $563.03 to $563.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2021 at each separate price. |